US

Limin Zheng


Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Limin Zheng - Innovator in Medical Immunology

Introduction

Limin Zheng is a notable inventor in the field of medical immunology, currently based in the United States. He has made significant contributions to the development of vaccines, particularly focusing on Clostridium difficile, a bacterium that can cause severe intestinal conditions.

Latest Patents

Limin Zheng holds a patent for a recombinant Toxin A/toxin B vaccine against Clostridium difficile. This invention relates to pharmaceutical compositions, methods of making, and methods of use of vaccines. Specifically, it involves recombinant proteins derived from the genes encoding Clostridium difficile toxin A and toxin B, aimed at creating an active vaccine against this harmful bacterium.

Career Highlights

Zheng is associated with Intercell USA, Inc., where he applies his expertise in immunology to advance vaccine development. His work is crucial in addressing the challenges posed by Clostridium difficile infections, which are a significant health concern.

Collaborations

He collaborates with esteemed colleagues such as Tracy D. Wilkins and David Maxwell Lyerly, contributing to a team effort in the pursuit of innovative solutions in medical science.

Conclusion

Limin Zheng's work in developing a vaccine against Clostridium difficile showcases his commitment to improving public health through innovative medical solutions. His contributions are vital in the ongoing fight against infectious diseases.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…